Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation

scientific article published in May 2009

Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JVS.2008.11.096
P932PMC publication ID3302687
P698PubMed publication ID19394554
P5875ResearchGate publication ID24360252

P2093author name stringBo Liu
K Craig Kent
Chunjie Wang
Dai Yamanouchi
Shirling Tsai
Rachel S Edlin
P2860cites workProliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularizationQ33895700
Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathwayQ34331098
Two major Smad pathways in TGF-beta superfamily signalling.Q35026971
Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis developmentQ35195495
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesionsQ35607475
Drug-eluting stents for infrainguinal occlusive disease: progress and challengesQ36510559
Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosisQ37866127
PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cellsQ40318266
Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferationQ40629500
CCR2 deficiency decreases intimal hyperplasia after arterial injuryQ43957593
The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferationQ44130114
Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen depositionQ45881572
The histologic characteristics of primary and restenotic carotid plaque.Q50524830
Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.Q51004193
Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.Q51211721
A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies.Q52318787
Replication in restenotic atherectomy tissueQ58657458
Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenosesQ71076696
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapyQ72225398
Apoptosis in human atherosclerosis and restenosisQ72256402
Analysis of atherectomy specimensQ72541316
Vascular remodeling. Honey, I think I shrunk the arteryQ72680148
Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaqueQ73286960
Histopathology of in-stent restenosis in patients with peripheral artery diseaseQ73303005
Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteriesQ74452823
Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosisQ74794174
Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growthQ77807906
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalanceQ78202550
Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injuryQ81575610
P4510describes a project that usesImageJQ1659584
P433issue5
P921main subjectatherosclerosisQ12252367
P304page(s)1289-1295
P577publication date2009-05-01
P1433published inJournal of Vascular SurgeryQ15755733
P1476titleCharacterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation
P478volume49

Reverse relations

cites work (P2860)
Q36679425A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation
Q39883888Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice
Q35838998Cell division cycle 7 is a novel regulator of transforming growth factor-β-induced smooth muscle cell differentiation
Q37348858Cell division cycle 7 mediates transforming growth factor-β-induced smooth muscle maturation through activation of myocardin gene transcription
Q42263710Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot study
Q50924514Effects of Different Simple Triglycerides on Cell Fatty Acid Compositions, Proliferation-Related Protein, and Gene Expressions Induced by Oxidized-LDL in HUVSMCs.
Q48599185Effects of Smad3 on the proliferation and steroidogenesis in human ovarian luteinized granulosa cells
Q33590493Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice
Q38843287Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis
Q24651685Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study
Q34076223Halofuginone stimulates adaptive remodeling and preserves re-endothelialization in balloon-injured rat carotid arteries
Q37420405Local CXCR4 Upregulation in the Injured Arterial Wall Contributes to Intimal Hyperplasia
Q35604813MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2.
Q38401252Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study
Q33814834Protein kinase C delta mediates arterial injury responses through regulation of vascular smooth muscle cell apoptosis
Q34712927RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima
Q55479087Role of Smad3 signaling in the epithelial‑mesenchymal transition of the lens epithelium following injury.
Q42426414Role of TGF-β1/Smad3 signaling pathway in secretion of type I and III collagen by vascular smooth muscle cells of rats undergoing balloon injury
Q35095828Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease
Q36042601TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells
Q34798852TGF-β and restenosis revisited: a Smad link
Q34007727TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.
Q21090638TGF-β/Smad3 stimulates stem cell/developmental gene expression and vascular smooth muscle cell de-differentiation
Q38205776The role of Notch pathway in cardiovascular diseases.
Q36079195The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model
Q48222456Time-dependent trends in cardiovascular adverse events during follow-up after carotid or iliofemoral endarterectomy
Q37882523Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects
Q42014388Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways